{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:28:29Z","timestamp":1762550909234,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020555","name":"Intas Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.nano.2025.102842","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:26:56Z","timestamp":1752607616000},"page":"102842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In situ miniemulsions of glimepiride using D-optimal mixture design-in silico, in vitro and in vivo studies"],"prefix":"10.1016","volume":"68","author":[{"given":"Niserga D.","family":"Sawant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bandoo C.","family":"Chatale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namita D.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2025.102842_bb0005","article-title":"Diabetes: mechanism, pathophysiology and management-a review","volume":"5","author":"Siddiqui","year":"2013","journal-title":"Int J Drug Dev Res [Internet]"},{"key":"10.1016\/j.nano.2025.102842_bb0010","unstructured":"Diabetes [Internet]. [cited 2021 Nov 15]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes."},{"key":"10.1016\/j.nano.2025.102842_bb0015","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/dc11-0442","article-title":"Globalization of diabetes","volume":"34","author":"Hu","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nano.2025.102842_bb0020","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/340838","article-title":"Recent trends in therapeutic approaches for diabetes management: a comprehensive update","volume":"2015","author":"Tiwari","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.nano.2025.102842_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0939-6411(00)00091-6","article-title":"Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards","volume":"50","author":"L\u00f6benberg","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2025.102842_bb0030","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.2147\/IJN.S105419","article-title":"Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique","volume":"11","author":"Li","year":"2016","journal-title":"IJN"},{"key":"10.1016\/j.nano.2025.102842_bb0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0939-6411(98)00041-1","article-title":"Biopharmaceutical characterization of oral immediate release drug products. In vitro\/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin","volume":"46","author":"Frick","year":"1998","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2025.102842_bb0040","doi-asserted-by":"crossref","first-page":"D237","DOI":"10.1093\/nar\/gkp970","article-title":"SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions","volume":"38","author":"Preissner","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nano.2025.102842_bb0045","first-page":"26","article-title":"Structural characterization of the hypoglycemic drug glimepiride","volume":"11","author":"Reges","year":"2018","journal-title":"International Journal of Recent Research and Review (2277\u20138322)"},{"key":"10.1016\/j.nano.2025.102842_bb0050","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/17425247.2016.1218462","article-title":"From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)","volume":"14","author":"Rehman","year":"2017","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2025.102842_bb0055","article-title":"Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems","author":"Gupta","year":"2013","journal-title":"ISRN Pharm"},{"key":"10.1016\/j.nano.2025.102842_bb0060","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/03639045.2016.1275665","article-title":"Self nanoemulsifying granules (SNEGs) of meloxicam: preparation, characterization, molecular modelling and evaluation of in vivo anti-inflammatory activity","volume":"43","author":"Parekh","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.nano.2025.102842_bb0065","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jconrel.2021.03.005","article-title":"Not only in silico drug discovery: molecular modelling towards in silico drug delivery formulations","volume":"332","author":"Casalini","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102842_bb0070","unstructured":"Legen I, Kerc J, Jurkovic P. Self-microemulsifying drug delivery systems [Internet]. 2013 [cited 2024 Jul 30]. Available from: https:\/\/patents.google.com\/patent\/US8592490B2\/en."},{"key":"10.1016\/j.nano.2025.102842_bb0075","unstructured":"Desai D, Vaka S, Shah Nh, Jain A, Phuapradit W. Self-nanoemulsion of poorly soluble drugs [Internet]. 2014 [cited 2024 Jul 30]. Available from: https:\/\/patents.google.com\/patent\/WO2014205226A1\/en."},{"key":"10.1016\/j.nano.2025.102842_bb0080","article-title":"Preparation and characterization of biodegradable glimepiride loaded PLA nanoparticles by o\/w solvent evaporation method using high pressure homogenizer: a factorial design approach introduction","volume":"1","author":"Mokale","year":"2014","journal-title":"SAJ Pharmacy and Pharmacology"},{"key":"10.1016\/j.nano.2025.102842_bb0085","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.addr.2007.05.006","article-title":"Oral lipid-based formulations","volume":"59","author":"Hauss","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102842_bb0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jpba.2007.10.030","article-title":"Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound","volume":"46","author":"Baka","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.nano.2025.102842_bb0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijpharm.2006.08.038","article-title":"Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil","volume":"329","author":"Date","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102842_bb0100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/10717544.2013.879753","article-title":"Solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of glimepiride: development and antidiabetic activity in albino rabbits","volume":"22","author":"Mohd","year":"2015","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2025.102842_bb0105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejpb.2004.03.037","article-title":"Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro\/in vivo investigation","volume":"58","author":"Huang","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2025.102842_bb0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.22146\/ijc.22640","article-title":"Design and optimization of self nano-emulsifying drug delivery system containing a new anti-inflammatory agent Pentagamavunon-0","volume":"17","author":"Astuti","year":"2017","journal-title":"Indones J Chem"},{"key":"10.1016\/j.nano.2025.102842_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106157","article-title":"Mesoporous silica-based amorphous solid dispersions to enhance the oral bioavailability of Neratinib maleate","volume":"101","author":"Mahajan","year":"2024","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/j.nano.2025.102842_bb0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3923\/pjn.2018.248.254","article-title":"Effect of Sargassum hystrix powder on the biochemical profile of diabetic Wistar rats","volume":"17","author":"Nurfahmi","year":"2018","journal-title":"Pakistan J of Nutrition"},{"key":"10.1016\/j.nano.2025.102842_bb0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.colsurfb.2015.06.027","article-title":"Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin","volume":"134","author":"Jain","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"author":"Bach","key":"10.1016\/j.nano.2025.102842_bb0130"},{"year":"2022","series-title":"Essentials of Physical Chemistry","author":"G.D BABBS& T","key":"10.1016\/j.nano.2025.102842_bb0135"},{"key":"10.1016\/j.nano.2025.102842_bb0140","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/pharmaceutics15030741","article-title":"Application of machine-learning algorithms for better understanding the properties of liquisolid systems prepared with three mesoporous silica based carriers","volume":"15","author":"Gli\u0161i\u0107","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102842_bb0145","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1208\/s12248-009-9114-3","article-title":"An investigation into the importance of \u201cvery rapid dissolution\u201d criteria for drug bioequivalence demonstration using gastrointestinal simulation technology","volume":"11","author":"Kovacevi","year":"2009","journal-title":"AAPS J"},{"issue":"suppl 2","key":"10.1016\/j.nano.2025.102842_bb0150","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u201cself-microemulsifying\u201d drug delivery systems","volume":"11","author":"Pouton","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2025.102842_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0169-409X(96)00490-5","article-title":"Formulation of self-emulsifying drug delivery systems","volume":"25","author":"Pouton","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102842_bb0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2010.03.008","article-title":"SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization","volume":"391","author":"Basalious","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102842_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/jps.23333","article-title":"Development and optimization of self-nanoemulsifying drug delivery system with enhanced bioavailability by Box\u2013Behnken design and desirability function","volume":"101","author":"Marasini","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2025.102842_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6640103","article-title":"Nanoemulsion: an emerging novel technology for improving the bioavailability of drugs","author":"Preeti","year":"2023","journal-title":"Scientifica"},{"key":"10.1016\/j.nano.2025.102842_bb0175","first-page":"61","article-title":"Comparative evaluation of porous silica based carriers for lipids and liquid drug formulations","volume":"1","author":"Reddy","year":"2014","journal-title":"Open Material Sciences"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:20:57Z","timestamp":1762550457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963425000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":35,"alternative-id":["S1549963425000437"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102842","relation":{},"ISSN":["1549-9634"],"issn-type":[{"type":"print","value":"1549-9634"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ miniemulsions of glimepiride using D-optimal mixture design-in silico, in vitro and in vivo studies","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102842"}}